[HTML][HTML] Inhibition of vascular adhesion protein-1 modifies hepatic steatosis in vitro and in vivo
EL Shepherd, S Karim, PN Newsome… - World journal of …, 2020 - ncbi.nlm.nih.gov
BACKGROUND Non-alcoholic fatty liver disease (NAFLD) is associated with obesity, insulin
resistance and dyslipidaemia and currently is estimated to affect up to a third of all …
resistance and dyslipidaemia and currently is estimated to affect up to a third of all …
[PDF][PDF] WJH
EL Shepherd, S Karim, PN Newsome, PF Lalor - World, 2020 - pdfs.semanticscholar.org
BACKGROUND Non-alcoholic fatty liver disease (NAFLD) is associated with obesity, insulin
resistance and dyslipidaemia and currently is estimated to affect up to a third of all …
resistance and dyslipidaemia and currently is estimated to affect up to a third of all …
Inhibition of vascular adhesion protein-1 modifies hepatic steatosis in vitro and in vivo
EL Shepherd, S Karim… - World journal of …, 2020 - publications.aston.ac.uk
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is associated with obesity, insulin
resistance and dyslipidaemia and currently is estimated to affect up to a third of all …
resistance and dyslipidaemia and currently is estimated to affect up to a third of all …
Inhibition of vascular adhesion protein-1 modifies hepatic steatosis in vitro and in vivo.
EL Shepherd, S Karim, PN Newsome… - World Journal of …, 2020 - europepmc.org
Background Non-alcoholic fatty liver disease (NAFLD) is associated with obesity, insulin
resistance and dyslipidaemia and currently is estimated to affect up to a third of all …
resistance and dyslipidaemia and currently is estimated to affect up to a third of all …
[引用][C] Inhibition of vascular adhesion protein-1 modifies hepatic steatosis in vitro and in vivo
EL Shepherd, S Karim… - World journal of …, 2020 - research.birmingham.ac.uk
Inhibition of vascular adhesion protein-1 modifies hepatic steatosis in vitro and in vivo —
University of Birmingham Skip to main navigation Skip to search Skip to main content …
University of Birmingham Skip to main navigation Skip to search Skip to main content …
Inhibition of vascular adhesion protein-1 modifies hepatic steatosis in vitro and in vivo
EL Shepherd, S Karim… - World journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Non-alcoholic fatty liver disease (NAFLD) is associated with obesity, insulin
resistance and dyslipidaemia and currently is estimated to affect up to a third of all …
resistance and dyslipidaemia and currently is estimated to affect up to a third of all …
Inhibition of vascular adhesion protein-1 modifies hepatic steatosis in vitro and in vivo
EL Shepherd, S Karim, PN Newsome… - World journal of …, 2020 - research.aston.ac.uk
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is associated with obesity, insulin
resistance and dyslipidaemia and currently is estimated to affect up to a third of all …
resistance and dyslipidaemia and currently is estimated to affect up to a third of all …
[HTML][HTML] Inhibition of vascular adhesion protein-1 modifies hepatic steatosis in vitro and in vivo
EL Shepherd, S Karim, PN Newsome… - World Journal of …, 2020 - wjgnet.com
BACKGROUND Non-alcoholic fatty liver disease (NAFLD) is associated with obesity, insulin
resistance and dyslipidaemia and currently is estimated to affect up to a third of all …
resistance and dyslipidaemia and currently is estimated to affect up to a third of all …
[PDF][PDF] WJH
B Chapman, M Sinclair, PJ Gow, AG Testro… - …, 2020 - publications.aston.ac.uk
BACKGROUND Non-alcoholic fatty liver disease (NAFLD) is associated with obesity, insulin
resistance and dyslipidaemia and currently is estimated to affect up to a third of all …
resistance and dyslipidaemia and currently is estimated to affect up to a third of all …
Inhibition of vascular adhesion protein-1 modifies hepatic steatosis in vitro and in vivo.
EL Shepherd, S Karim, PN Newsome… - World Journal of …, 2020 - europepmc.org
Background Non-alcoholic fatty liver disease (NAFLD) is associated with obesity, insulin
resistance and dyslipidaemia and currently is estimated to affect up to a third of all …
resistance and dyslipidaemia and currently is estimated to affect up to a third of all …